Mentioned On
Episode Mentions
Biotech Hangout · May 8, 2026
Episode 182 - May 8, 2026
“Acquired by UCB for $2 billion; CEO Ken Song's second attempted public company exit; licensed assets from China”
Biotech Secondary Capital Raises and Market SaturationFDA Regulatory Uncertainty and Commissioner McCary LeadershipM&A Activity in Biotech and Venture Capital Returns
View Analysis